Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pathogenesis of multiple sclerosis.

× No keyword cloud information.

36 in total

Review 1. Monoclonal antibody therapy in experimental allergic encephalomyelitis and multiple sclerosis.

Authors: Xu Zhang; Raymond Hupperts; Marc De Baets
Journal: Immunol Res Date: 2003 Impact factor: 2.829

Review 2. The role of interleukin-1 in the pathogenesis of IDDM.

Authors: T Mandrup-Poulsen
Journal: Diabetologia Date: 1996-09 Impact factor: 10.122

Review 3. Cytokines, signal transduction, and inflammatory demyelination: review and hypothesis.

Authors: R W Ledeen; G Chakraborty
Journal: Neurochem Res Date: 1998-03 Impact factor: 3.996

4. Extensive vascular remodeling in the spinal cord of pre-symptomatic experimental autoimmune encephalomyelitis mice; increased vessel expression of fibronectin and the α5β1 integrin.

Authors: Amin Boroujerdi; Jennifer V Welser-Alves; Richard Milner
Journal: Exp Neurol Date: 2013-09-20 Impact factor: 5.330

5. Neuroinvasion by human respiratory coronaviruses.

Authors: N Arbour; R Day; J Newcombe; P J Talbot
Journal: J Virol Date: 2000-10 Impact factor: 5.103

Review 6. Multiple sclerosis: an altered immune response or an altered stress response?

Authors: J M van Noort
Journal: J Mol Med (Berl) Date: 1996-06 Impact factor: 4.599

7. Multiple sclerosis-associated virus-related pol sequences found both in multiple sclerosis and healthy donors are more frequently expressed in multiple sclerosis patients.

Authors: Jerzy Nowak; Danuta Januszkiewicz; Monika Pernak; Izabela Liweń; Mariola Zawada; Jolanta Rembowska; Karina Nowicka; Krzysztof Lewandowski; Hanna Hertmanowska; Mieczyslaw Wender
Journal: J Neurovirol Date: 2003-02 Impact factor: 2.643

8. RNA interference as a potential therapeutic treatment for inflammation associated lung injury.

Authors: Joanne Lomas-Neira; Chun-Shiang Chung; Alfred Ayala
Journal: Int J Clin Exp Med Date: 2008-02-25

Review 9. Health-related quality of life in multiple sclerosis: current evidence, measurement and effects of disease severity and treatment.

Authors: Richard A Rudick; Deborah M Miller
Journal: CNS Drugs Date: 2008 Impact factor: 5.749

10. Natalizumab for the treatment of relapsing multiple sclerosis.

Authors: Richard A Rudick; Michael A Panzara
Journal: Biologics Date: 2008-06